pharmaceuticals Article Lipoxygenase Inhibition Activity of Coumarin Derivatives—QSAR and Molecular Docking Study Melita Lonˇcari´c 1 , Ivica Strelec 1 , Valentina Pavi´c 2 , Domagoj Šubari´c 3, Vesna Rastija 3 and Maja Molnar 1,* 1 Faculty of Food Faculty Osijek, Josip Juraj Strossmayer University, 31000 Osijek, Croatia;
[email protected] (M.L.);
[email protected] (I.S.) 2 Department of Biology, Josip Juraj Strossmayer University of Osijek, 31000 Osijek, Croatia;
[email protected] 3 Department of Agroecology and Environmental Protection, Faculty of Agrobiotechnical Sciences Osijek, Josip Juraj Strossmayer University of Osijek, 31000 Osijek, Croatia;
[email protected] (D.Š.);
[email protected] (V.R.) * Correspondence:
[email protected]; Tel.: +385-31-224-342 Received: 2 July 2020; Accepted: 15 July 2020; Published: 17 July 2020 Abstract: Lipoxygenases (LOXs) are a family of enzymes found in plants, mammals, and microorganisms. In animals and plants, the enzyme has the capability for the peroxidation of unsaturated fatty acids. Although LOXs participate in the plant defense system, the enzyme’s metabolites can have numerous negative effects on human health. Therefore, many types of research are searching for compounds that can inhibit LOXs. The best quantitative structure–activity relationship (QSAR) model was obtained using a Genetic Algorithm (GA). Molecular docking was performed with iGEMDOCK. The inhibition of lipoxygenase was in the range of 7.1 to 96.6%, and the inhibition of lipid peroxidation was 7.0–91.0%. Among the synthesized compounds, the strongest inhibitor of soybean LOX-3 (96.6%) was found to be 3-benzoyl- 7-(benzyloxy)-2H-chromen-2-one.